Research on a drug for treating the most frequent chemotherapy disorders

Attention: open in a new window. PDFPrintE-mail
  • Currently 2.74/5
2.7/5 (65 votes)

The biotech company – specialised in nanomedicine and cell methods for in vitro research, and located at the Barcelona Science Park- has signed an agreement with the company Nobera Pharma for the development of a drug aimed at treating palmar-plantar erythrodysesthesia. Also known as the hand-foot syndrome, it is a very frequent side effect in cancer patients that leads to the reduction and even interruption of chemotherapy, decreasing chances of survival.

The drug is currently in the pre-clinical phase, and it is forecasted that clinical studies will begin during the first trimester of 2010. Its objective is to ensure that patients complete their chemotherapy treatment before the expected pause, as well as to substantially improve their quality of life during treatment.

For more information: Barcelona Science Park

Become a member of the NANOYOU Schools’ Community!

Schools from all over Europe are already teaching NT in their classrooms and sharing their experience and best practices in the NANOYOU Schools’ Community.

Click here for more information on the Schools' Community and on how to register.

For more news on Nanotechnology visit AlphaGalileo

If you want to read more news on Nanotechnologies and their last developments visit AlphaGalileo, the Europe's leading source of research news.

Educators: We need your feedback!

The NANOYOU project is reaching its end and we need your feedback to evaluate its impact.
Please answer this questionnaire.

Check all the NANOYOU tools!

Visit the tools' map to see all the resources that NANOYOU has developed.

Do you want to see what the NANOYOU schools are doing?

Visit the teachers' blog and discover what the NANOYOU schools are doing through pictures, videos and posts!

Watch the NANOYOU videos in

Visit the picture gallery on:

Share your resources and your favourites

NANOYOU portal aims to gather resources and information on Nanotechnologies and Nanoscience so that all the visitors have access to it. Collaborate with us sharing your resources and your favourites.